Abstract
PurposeThe study aims to explore the interplay between open innovation and intellectual property. Differently from previous studies, we argue that open innovation fosters firm's patenting activity.Design/methodology/approachWe use linear regression analysis to test model's hypotheses. Data are drawn from the Eurostat statistics and refer to a large sample of European firms (NACE Rev.2).FindingsThe findings confirm that open innovation fosters patenting activity in health care, also thanks to huge governments' expenditures in this market.Research limitations/implicationsThe study focuses solely on European firms and it adopts a traditional linear approach. So, we cannot exclude that different dynamics may occur across European borders. Future research should address this concern by focusing on multi-country comparative studies.Practical implicationsOpen innovation is the most suitable model for health industry, because it improves both innovation performance and intellectual capital of firms.Originality/valueThe study tackles an existing gap of the literature by considering how the presence of large customers impacts the strength of intellectual property protection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
